Skip to content
Transchem logo

Transchem

500422 BSE
Price unavailable

Transchem (TRANSCHEM) share price was ₹407.85 at the 27 Oct 2026 close; P/E (TTM) 74.29; sector Healthcare. The share price rose 451.6% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was ₹3.42 Cr, against ₹0.99 Cr a year earlier (compared with Jun 2025). Promoters held 56.45% of Transchem in Jun 2026, unchanged from Mar 2026.

Close 27 Oct 2026 ₹407.85 +336.23 +469.46% 1Y

Peer Comparison

Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,766.7035.054,23,891 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
₹4,610.5072.381,75,369 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
₹2,188.00108.101,18,220 Cr22.310.09%16.38%19.67%7,323 Cr1,090 Cr
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
₹1,364.8032.701,10,257 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
—73.85496 Cr5.940.00%5.14%6.70%13 Cr7 Cr
Transchem (this company)
—————————
Median 9 companies₹1,766.7053.721,18,028 Cr5.510.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Stock is trading at 6.08 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.98% over last 3 years.
  • Earnings include an other income of Rs.12.7 Cr.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bullish

Bearish
6
Neutral
5
Bullish
8

Moving Averages

Bullish

Bearish
4
Neutral
0
Bullish
6

Growth Rate

Revenue Growth
-100%

change over 1 year

Net Income Growth
48% lower than 3Y

change over 1 year

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0.41
0
0
0.21
2.42
0
0
0
0
0
Expenses
0.4
0.39
0.5
0.86
0.27
0.37
0.54
2.9
0.29
0.75
1.31
1.31
0.7
Operating Profit
-0.4
-0.39
-0.5
-0.45
-0.27
-0.37
-0.33
-0.48
-0.29
-0.75
-1.31
-1.31
-0.7
OPM %
—
—
—
-109.76%
—
—
-157.14%
-19.83%
—
—
—
—
—
Other Income
1.53
1.69
2.02
2.16
2.47
2.31
2.19
1.56
1.64
1.68
2.25
3.7
5.11
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0.05
PBT
1.13
1.3
1.52
1.71
2.2
1.94
1.86
1.08
1.35
0.93
0.94
2.39
4.35
Tax %
24.78%
25.38%
25.66%
26.9%
24.09%
25.26%
25.27%
32.41%
26.67%
27.96%
43.62%
12.55%
21.38%
Net Profit
0.85
0.97
1.14
1.25
1.66
1.44
1.39
0.73
0.99
0.68
0.53
2.09
3.42
EPS (₹)
0.69
0.79
0.93
1.02
1.36
1.18
1.14
0.6
0.81
0.56
0.43
1.71
2.79
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0
-0.05
-0.2
0
0.34
2.63
0
0
Expenses
0.78
0.93
0.98
1.69
1.18
1.39
1.88
2.54
1.73
2.08
4.09
3.63
4.07
Operating Profit
-0.78
-0.93
-0.98
-1.69
-1.18
-1.39
-1.93
-2.74
-1.73
-1.74
-1.46
-3.63
-4.07
OPM %
—
—
—
—
—
—
—
—
—
-511.76%
-55.51%
—
—
Other Income
2.09
1.97
1.78
2.11
2.75
2.76
26.82
6.66
4.24
7.4
8.53
9.25
12.74
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
1.07
1.02
1.02
0.97
0.8
0.57
0.12
0.01
0.01
0.01
0.01
0.01
0.05
PBT
0.24
0.02
-0.22
-0.55
0.77
0.8
24.77
3.91
2.5
5.65
7.06
5.61
8.61
Tax %
45.83%
-150%
0%
116.36%
61.04%
47.5%
2.5%
26.6%
50.8%
25.66%
26.06%
23.53%
—
Net Profit
0.12
0.05
-0.22
-1.19
0.31
0.41
24.15
2.87
1.24
4.2
5.23
4.3
6.72
EPS (₹)
0.1
0.04
-0.18
-0.97
0.25
0.33
19.73
2.34
1.01
3.43
4.27
3.51
5.49
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
Reserves
26.11
26.15
25.75
24.57
25.74
24.53
50.7
54.06
53.6
63.41
67.08
71.34
Borrowings
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0.22
0.23
0.17
0.17
0.39
0.3
0.48
0.51
0.39
0.66
0.4
4.15
Total Liabilities
38.57
38.62
38.16
36.98
38.37
37.07
63.42
66.81
66.23
76.31
79.72
87.73
Fixed Assets
8.4
7.42
6.4
5.43
4.27
3.7
0.11
0.1
0.09
0.09
0.05
0.02
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
27.5
28.01
29.79
10.21
5.93
3.69
8.69
8.82
8.23
8.91
2.04
1.97
Other Assets
2.67
3.19
1.97
21.34
28.17
29.68
54.62
57.89
57.91
67.31
77.63
85.74
Total Assets
38.57
38.62
38.16
36.98
38.37
37.07
63.42
66.81
66.23
76.31
79.72
87.73
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.94
1.08
0.55
-19.79
10.34
-0.63
-27.72
21.91
1.22
-39.31
36
-2.89
Investing
-1.21
-0.26
-1.51
19.78
5.73
0.67
23.06
0.6
-0.94
5.12
6.02
1.65
Financing
0
0
0
0
0
0
0
0
0
0
0
0
Net Cash Flow
-0.27
0.83
-0.95
-0.01
16.07
0.04
-4.66
22.51
0.28
-34.18
42.02
-1.24
Free Cash Flow
0.94
1.04
0.55
-19.79
10.53
-0.63
-1.79
21.91
1.22
-39.31
36.53
-1.31
CFO/OP
-121
-116
-56
1,165
-897
0
1,401
-853
-132
2,182
-2,618
47
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
—
—
—
—
—
440
376
—
Inventory Days
—
—
—
—
—
—
—
—
—
0
0
—
Cash Conversion Cycle
—
—
—
—
—
—
—
—
—
440
376
—
Working Capital Days
—
—
—
—
—
—
—
—
—
71,422
4,856
—
ROCE %
0.63%
0.05%
-0.58%
-1.47%
1.63%
2.03%
4.61%
4.22%
3.5%
7.99%
9.11%
6.9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Transchem insights

29 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

DIIs0.01%Promot.56.45%FIIs0.03%Public43.52%As ofJun 2026

Documents

Frequently Asked Questions about Transchem

What does Transchem Ltd do?
Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]
Where is Transchem Ltd (TRANSCHEM) listed?
Transchem Ltd trades under code 500422 on the BSE.
Which sector does Transchem Ltd belong to?
Transchem Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the PE ratio of Transchem Ltd?
Transchem Ltd trades at a PE ratio of 74.29 as of 27 Oct 2026, on earnings per share of ₹5.49.

Company Information

Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TRANSCHEM.md for Transchem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More